REG - File Forge Tech. - Completion of Acquisition and Admission to Trading

Hydrogen Utopia InternationalAnnouncement

06/06/2025 08:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250606:nRSF6780La&default-theme=true

RNS Number : 6780L  File Forge Technology PLC  06 June 2025

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication
of this announcement via a Regulatory Information Service, this inside
information is now considered to be in the public domain.

6 June 2025

File Forge Technology PLC (to be renamed Amirose London Holdings PLC)

 

("File Forge" or the "Company")

 

Completion of Acquisition of Amirose London Ltd

 

Admission of Enlarged Share Capital to Trading on the Access Segment of the
Aquis Stock Exchange

 

File Forge Technology PLC (to be renamed Amirose London Holdings PLC), is
pleased to announce the completion of its acquisition of Amirose London Ltd
and the admission of its enlarged share capital of 117,483,865 ordinary shares
of £0.024 each ("Ordinary Shares") at an issue price of 5p each to trading on
the Access Segment of the Aquis Stock Exchange from 8am on 6 June 2025
("Admission").

 

The Company's  change of name to Amirose London Holdings PLC will be
effective once Companies House has issued a new certificate of incorporation
reflecting the change of name. The ticker 'ALH' is effective immediately.

 

Alfred Henry Corporate Finance Ltd has been appointed corporate finance
advisor from Admission.

 

From Admission, the Company's website is: https://amiroselondon.com
(https://amiroselondon.com)

 

Michael Heath, Chief executive Officer of Amirose London Holdings PLC,
commented: "Today marks a significant milestone in Amirose's journey. Being
listed on the Aquis Stock Exchange is not only a testament to the strength of
our team and business model, but also a gateway to new opportunities for
growth and value creation. We're excited to begin this new chapter and thank
our investors and employees for their support."

 

Amirose

 

Amirose provides contract manufacturing services in the personal care sector
for global and boutique premium brands. Amirose will assist such brands in
developing formulations for personal care products, sourcing packaging, bulk
manufacturing, filling and distributing. Amirose also helps customers navigate
the regulatory and compliance framework required to bring a product to market.
Amirose has approximately 75 customers and services over 200 brands. Amirose's
manufacturing facilities are in Thetford, Norfolk. Amirose currently has 86
employees.

 

Amirose aims to transform its contract manufacturing business, which has so
far generated modest profits while utilising only a portion of its factory's
capacity, into a thriving enterprise by fully leveraging excess capacity,
infrastructure, and the expertise of its team. Amirose expects to drive growth
organically and through strategic acquisitions in the future.

 

Turnover for the year ended 30.03.24 was £12.7m and profits £38.8k. Draft
unaudited accounts for the year ended 30.3.25 showed a turnover of
approximately £11m and breakeven EBITDA.

 

Fundraising

 

A total of £245,500 was raised on Admission by way of subscription.

 

A further £65,000 has been raised by way of a placing to provide additional
working capital for Amirose London Ltd's contract manufacturing services.

 

Application has been made for the 1,300,000 placing shares to be admitted to
trading and it is expected that admission of the placing shares will take
place on, or around, 9 June 2025. The placing shares will rank pari passu in
all respects with the existing ordinary shares of the Company.

 

This amount is in addition to the £245,500 subscribed in the context of the
Admission.

 

Market Capitalisation

 

The Company's market capitalisation on Admission is £5,874,193.

 

Senior Management Team

 

Michael Heath (Chief Executive Officer and Finance Director)

Michael is the current CEO and Financial Officer of Amirose. Michael is a
Chartered Management Accountant with over 10 years of experience in the
personal care manufacturing industry. Michael holds a BA (Hons) in
Accounting & Finance and is a member of the Chartered Institute of
Management Accountants (CIMA).

 

Aleksandra Binkowska (Non-Executive Chairman)

Aleksandra is the founder and CEO of Hydrogen Utopia International PLC, a
company listed on the London Stock Exchange, pioneering solutions in plastic
waste-to-hydrogen technology. Aleksandra studied Political Sciences and
Journalism at Warsaw University.

 

Mitchell Field (Non-Executive Director)

Mitchell Field brings over 50 years of experience in the health and beauty
manufacturing sector. With a background in psychology, he has played a pivotal
role in building and developing sales teams, focusing on strategies to retain
and grow the client base. Between 1971 - 1975, Mitchell obtained a Bachelor of
Science in Psychology and a B -Tech in Psychology from Brunel University in
London. He taught Psychology at teachers' training colleges from 1989 -
1991.

 

David Battle (Independent Non-Executive Director)

David Battle is currently an advisor introducing smaller companies to the UK
capital market and suitable potential fundraising partners. David has been
working in UK capital markets for smaller companies for 10 years, 5 of which
were served as Managing Director responsible for the business and market
development of NEX Exchange (Aquis predecessor) until 2019.

 

Total Voting Rights

Following Admission today, the Company's enlarged issued ordinary share
capital will comprise 117,483,865 Ordinary Shares. The Company does not hold
any Ordinary Shares in treasury. Therefore, from Admission until close of
business on 8 June 2025, 117,483,865  may be used by shareholders in the
Company as the denominator for the calculations to determine if they are
required to notify their interest in, or a change to their interest in the
Company, under the FCA's Disclosure Guidance and Transparency Rules.

From 9 June 2025, the Company's enlarged issued ordinary share capital will
comprise 118,783,865   Ordinary Shares. Accordingly, from that date, the
figure of 118,783,865 should be used as the denominator for such calculations.

The Directors of the Company accept responsibility for this announcement.

For further information please contact:

 File Forge (to be renamed Amirose London Holdings PLC)  +44 7391 407 210

 Michael Heath

 Chief Executive Officer
 Corporate Advisor                                       +44 (0) 20 8064 4056

 Alfred Henry Corporate Finance

 
 Nick Michaels/Maya Klein Wassink
 Company Brokers

 Capital Plus Partners Limited                           +44 (0) 7799 888 544

 Dominic Berger

 Novum Securities Limited                                +44 20 7399 9400

 Jon Belliss/Colin Rowbury

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXBUGDLLGGDGUU